Agilent Product Profile
Pre-tested, pre-configured GC and GC/MS Analyzers get you the results you need—fast!
To help your lab get a new application workflow up and running as quickly and as cost-effectively as possible, Agilent has put together an extensive portfolio of chemically pre-tested, pre-configured Analyzer solutions. All come ready-to-run, with proven analysis methods and checkout samples that can reduce your method development costs by up to 90%.
Backed by world-class application experts and more than 40 years of industry partnership, Agilent GC and GC/MS Analyzers include:
Learn how Agilent GC and GC/MS Analyzers can help you produce the consistent, high-quality data your laboratory depends on—right from day one.
To get all the details, contact your local Agilent Representative or Agilent Authorized Distributor. Or visit:
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.